MGTX
MGTX
NASDAQ · Biotechnology

Meiragtx Holdings Plc

$9.84
+0.16 (+1.65%)
As of May 9, 1:45 AM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 13 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +540.3% upside
Low Target $47.40
Average Target $63.01
High Target $83.78
Current Price $9.84
Current
$9.84
Target
$63.01
$47.40 $63.01 avg $83.78
Scenario Analysis
Bear Case
$47.40
381.7%
Low target
Base Case
$63.01
+540.3%
Avg target
Bull Case
$83.78
+751.4%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$11.85
-17.0% from high
52-Week Low
$4.55
+116.3% from low
Target vs 52W High
$63.01
+431.7% vs high
Next Earnings Report
May 11, 2026
Today
EPS Est: $-0.41
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
Strong Buy 28 96% $143.40 +41.5%